ag视讯打不开-AG全讯网puma

Faculty

中文       Go Back       Search
Chengqing Ning
Research Associate Professor
0755-88018396
ningcq@sustech.edu.cn

Education

    2011-2015 Central South University, Medicinal Chemistry, PhD

    2008-2011 Central South University, Medicinal Chemistry, MS

    2004-2008 Jiangxi University of Traditional Chinese Medicine, Pharmacy, BS

Work Experience

    2021-present, SUSTech, Research Associate Professor

    2018-2020,SUSTech, Research Assistant Professor

    2015-2017,SUSTech,  Postdoc.

Research Areas

    The major research focus of Dr. Ning is the design and synthesis of novel small molecules as anticancer and/or antiinflammatory agents through using structural analyses (such as molecular modeling), SAR studies, and biochemical assays. Identification of novel inflammatory inhibitors for the treatment of neurodegenerative disease, especially for the treatment of Alzheimer’s disease and multiple sclerosis.

Publications

  1. Shengling Xie, Pan Ren, Jieping Hou, Chengqing Ning*, Jing Xu*. Stereoselective Synthesis of the ABC Ring System of Aspterpenacids. Journal of Organic Chemistry, 2018, 83, 14152-14157.

  2. Chengqing Ning, Liumei Mo, Xuwei Chen, Wentong Tu, Jun Wu*, Shengtao Hou*, Jing Xu*. Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure–activity relationship studies, Bioorganic & Medicinal Chemistry Letters, 2018, 28(4): 689-693.

  3. Wentong Tu, Chengqing Ning*, Jing Xu*. Enantioselective synthesis of (-)-phaseic acid, Organic Chemistry Frontiers, 2018, 5(1): 29-31.

  4. Chengqing Ning, Cheng Lu, Liang Hu, Yanjing Bi, Lei Yao, Yujun He, Lifei Liu, Xiaoyu Liu*, Niefang Yu*. Macrocyclic compounds as anti-cancer agents: design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2. European Journal of Medicinal Chemistry. 2015, 95, 104-115.

  5. Chengqing Ning,Wenyuan Huang, Wen Wu, Cheng Lu, Yujun He, Lei Yao, Lifei Liu, Xiaohe Zhen, Xiaoyu Liu*, Niefang Yu*. Discovery of novel potent HDAC inhibitors by structure-based optimization of cinnamic hydroxamic scaffold. Letters in Drug Design & Discovery. 2015, 12, 344-350.

  6. Chengqing Ning, Yanjing Bi, Yujun He, Wenyuan Huang, Lifei Liu, Yi Li, Sihan Zhang, Xiaoyu Liu, Niefang Yu*. Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 2013, 23, 6432–6435.


万宝路百家乐的玩法技巧和规则 | 真人百家乐官网网西陆| K7百家乐官网的玩法技巧和规则 | 百家乐庄闲筹码| 海王星开户| 免费百家乐官网计划软件| 六合彩印刷图库| 百家乐官网博弈之赢者理论| 做生意挂什么画招财| 娱乐城开户送彩金| 百家乐网站排行| 久盛国际| 百家乐玄机| 百家乐官网娱乐平台代理佣金| 在线博彩网| 极速百家乐真人视讯| 百家乐官网筹码盒| 金沙国际娱乐城| 什么百家乐九宫三路| 属龙属虎合伙做生意吗| 永利博百家乐官网游戏| 百家乐赌博机销售| 全讯网即时线路| 做生意风水 门对门| 百家乐官网双人操作分析仪| 信誉棋牌游戏| 广东百家乐桌布| 澳门金莎娱乐城| 大中华百家乐的玩法技巧和规则| 百家乐官网怎么发牌| 句容市| 大发888 大发888娱乐城| 百家乐官网百家乐官网视频游戏世界| 大发888娱乐场下载| 百家乐龙虎台布作弊技巧| 百家乐官网桌布动物| 百家乐官网娱乐平台会员注册| 正规百家乐平注法口诀| 澳门百家乐官网网上直赌| 上杭县| 武宁县|